BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1579807)

  • 1. An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue.
    Sudderick RM; Lund VJ; Thomson JP; McCombe A; Mackay IS
    Rhinology; 1992 Mar; 30(1):11-6. PubMed ID: 1579807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefuroxime axetil in the treatment of sinusitis. A review.
    Pakes GE; Graham JA; Rauch AM; Collins JJ
    Arch Fam Med; 1994 Feb; 3(2):165-75. PubMed ID: 7994439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of cefuroxime into bronchial mucosa following oral administration of cefuroxime axetil.
    Winter J; Dhillon P
    J Antimicrob Chemother; 1991 Apr; 27(4):556-8. PubMed ID: 1856136
    [No Abstract]   [Full Text] [Related]  

  • 4. Penetration of cefuroxime into chronically inflamed sinus mucosa.
    Dinis PB; Monteiro MC; Lobato R; Martins ML; Gomes A
    Laryngoscope; 1999 Nov; 109(11):1841-7. PubMed ID: 10569419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of oral cefuroxime axetil into the human aqueous humor.
    Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
    Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
    Stoeckel K; Harell M; Dan M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
    Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
    Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R; Gehanno P; Nikolaidis P; Bagger-Sjöbäck D; Ibanez JM; Hampel B; Sommerauer B
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
    Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefuroxime axetil].
    Matsumoto F; Oizumi K
    Jpn J Antibiot; 1988 Sep; 41(9):1181-93. PubMed ID: 3071614
    [No Abstract]   [Full Text] [Related]  

  • 11. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
    Klein GL; Whalen E; Echols RM; Heyd A
    J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
    Brink HS; Huisman RM; Geerlings W; de Jong PE
    Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cefuroxime-axetil in the treatment of acute sinusitis in adults. Comparative study with cefaclor].
    Freche C; Fombeur JP; Pappo M
    Therapie; 1988; 43 Suppl 4():365-8. PubMed ID: 3222778
    [No Abstract]   [Full Text] [Related]  

  • 15. Model simulation of a single oral dose of cefuroxime axetil and the related in-vitro kill kinetics against four bacterial species.
    Silley P; Monsey D; Harris AM
    J Antimicrob Chemother; 1990 Jan; 25(1):83-90. PubMed ID: 2180892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
    James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue penetration following orally administered cefuroxime axetil.
    Wise R
    J Chemother; 1989 Jul; 1(4 Suppl):515-6. PubMed ID: 16312510
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amoxycillin-clavulanic acid and cefuroxime axetil in the treatment of acute sinusitis. A clinical, radiological and bacteriological evaluation].
    Olmo A; Sabater F; Broto J; Traserra J
    Acta Otorrinolaringol Esp; 1994; 45(1):25-9. PubMed ID: 8204290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis.
    Upchurch J; Rosemore M; Tosiello R; Kowalsky S; Echols R
    Otolaryngol Head Neck Surg; 2006 Oct; 135(4):511-7. PubMed ID: 17011409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of cefuroxime axetil and amoxycillin in the treatment of acute sinusitis in general practice.
    Brodie DP; Knight S; Cunningham K
    J Int Med Res; 1989; 17(6):547-51. PubMed ID: 2628131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.